Federated Hermes, Inc. Abbott Laboratories Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Federated Hermes, Inc. holds 758,216 shares of ABT stock, worth $85.2 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

758,216

Previous 760,781 0.34%

Holding current value

$85.2 Million

Previous $79.1 Million 9.35%

% of portfolio

0.2%

Previous 0.19%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $256,679 - $303,003	-2,565 Reduced 0.34%	758,216 $86.4 Million
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $11.1 Million - $12.4 Million	-110,149 Reduced 12.65%	760,781 $79.1 Million
Q1 2024 May 14, 2024	SELL	$109.52 - $120.96 $21.2 Million - $23.5 Million	-193,978 Reduced 18.22%	870,930 $99 Million
Q4 2023 Jan 31, 2024	SELL	$90.19 - $110.4 $2.05 Million - $2.51 Million	-22,738 Reduced 2.09%	1,064,908 $117 Million
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $13.5 Million - $16.2 Million	-141,769 Reduced 11.53%	1,087,646 $105 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $9.42 Million - $10.5 Million	-93,507 Reduced 7.07%	1,229,415 $134 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $19.8 Million - $23.3 Million	204,410 Added 18.28%	1,322,922 $134 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $13.6 Million - $16 Million	-143,163 Reduced 11.35%	1,118,512 $123 Million
Q3 2022 Nov 14, 2022	SELL	$96.76 - $112.03 $1.39 Million - $1.61 Million	-14,396 Reduced 1.13%	1,261,675 $122 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $21.1 Million - $25.5 Million	-206,655 Reduced 13.94%	1,276,071 $139 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $1.37 Million - $1.67 Million	-12,021 Reduced 0.8%	1,482,726 $175 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $2.92 Million - $3.57 Million	25,236 Added 1.72%	1,494,747 $210 Million
Q3 2021 Nov 15, 2021	BUY	$116.66 - $129.06 $6.22 Million - $6.89 Million	53,349 Added 3.77%	1,469,511 $174 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $53.4 Million - $62.8 Million	-504,593 Reduced 26.27%	1,416,162 $164 Million
Q1 2021 May 13, 2021	BUY	$108.84 - $128.23 $10.2 Million - $12 Million	93,962 Added 5.14%	1,920,755 $230 Million
Q4 2020 Feb 12, 2021	BUY	$105.0 - $114.42 $1.85 Million - $2.02 Million	17,613 Added 0.97%	1,826,793 $200 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $140,575 - $170,718	-1,534 Reduced 0.08%	1,809,180 $197 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $16.3 Million - $20.9 Million	-213,100 Reduced 10.53%	1,810,714 $166 Million
Q1 2020 May 13, 2020	BUY	$62.82 - $91.86 $7.96 Million - $11.6 Million	126,651 Added 6.68%	2,023,814 $160 Million
Q4 2019 Feb 14, 2020	BUY	$78.51 - $87.4 $10.3 Million - $11.4 Million	130,635 Added 7.4%	1,897,163 $165 Million
Q3 2019 Nov 14, 2019	SELL	$81.84 - $88.74 $18.2 Million - $19.7 Million	-222,512 Reduced 11.19%	1,766,528 $148 Million
Q2 2019 Aug 14, 2019	BUY	$72.88 - $85.0 $468,035 - $545,870	6,422 Added 0.32%	1,989,040 $167 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $4.33 Million - $5.24 Million	-65,408 Reduced 3.19%	1,982,618 $158 Million
Q4 2018 Feb 13, 2019	SELL	$65.56 - $74.27 $2.96 Million - $3.35 Million	-45,144 Reduced 2.16%	2,048,026 $148 Million
Q3 2018 Nov 13, 2018	BUY	$60.81 - $73.36 $118 Million - $143 Million	1,943,772 Added 1301.07%	2,093,170 $154 Million
Q2 2018 Aug 10, 2018	SELL	$57.57 - $63.54 $15.8 Million - $17.5 Million	-274,951 Reduced 64.79%	149,398 $9.11 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $230,819 - $260,969	4,102 Added 0.98%	424,349 $25.4 Million
Q4 2017 Feb 14, 2018	BUY	$53.68 - $57.47 $8.68 Million - $9.29 Million	161,720 Added 62.55%	420,247 $0
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $12.4 Million - $13.9 Million	258,527	258,527 $13.8 Million

Others Institutions Holding ABT

# of Institutions

3,189

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Abbott Laboratories Transaction History